Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

The National Parkinson Foundation Welcomes Two New Board Members

MIAMI,FL — The National Parkinson Foundation (NPF) announced the election of two new members to its Board of Directors: Gregory E. Katz and Jonathan Levin.

"We are pleased to add more firepower to NPF's Board," stated John W. Kozyak, Esq., NPF Chairman of the Board. "Both Gregory and Jonathan know from their own families how devastating Parkinson's can be. They bring a keen business acumen that will help move the mission of NPF forward to make life better for people with Parkinson's and their families."

Gregory E. Katz was elected to the board in March 2015. Mr. Katz joined Newmark Grubb Knight Frank as vice chairman, Miami, in January 2015, bringing with him 25 years of commercial real estate experience. As a tenant representative, Mr. Katz has secured millions of dollars in occupancy cost savings and lease enhancements for his clients. His specific areas of expertise include strategic planning, workplace optimization, complex lease and financial restructurings, traditional leases and build-to-suit transactions. Prior to joining Newmark Grubb Knight Frank, Mr. Katz was an executive vice president with Studley (now Savills Studley). Mr. Katz earned a Bachelor of Science degree in business management from Tulane University. 

Jonathan Levin was elected to the board in March 2015. Jonathan Levin is a principal at The Williams Capital Group, L.P., an institutional investment bank based in New York servicing corporations as well as institutional investors active in the fixed income and equity capital markets. As Williams Capital's Director of Corporate Finance, Jonathan's responsibilities include managing the Firm's marketing and execution services for Fortune 500 corporations. Prior to joining Williams Capital in 1997, Jonathan served as a senior vice president in the Investment Banking Division of Lehman Brothers with responsibility for new business development, and the execution of corporate finance and merger and acquisition transactions primarily for commercial banking institutions. Jonathan received a Bachelor's degree in Economics from Duke University, and MBA and JD degrees from Northwestern University.

View a complete list of the NPF Board of Directors.

About Parkinson's Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Monday, April 6, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.